Louise Kooij
Vermogen: 79 249 $ op 31-05-2026
Vermogen: 79 249 $ op 31-05-2026
Louise Kooij is currently Chief Accounting Officer at NewAmsterdam Pharma Co. NV since 2023.
Formerly, Ms. Kooij was Head-Finance & Operations at Azafaros BV from 2020 to 2023, Head-Rare Disease at Genzyme Therapeutics Ltd. from 2018 to 2020, Product Group Accountant at Hagemeyer NV, and Auditor at PricewaterhouseCoopers BV.
Ms. Kooij graduated from Nyenrode Business Universiteit.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 22-06-2026 | 2.353 ( 0% ) | 79 249 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Comptroller/Controller/Auditor | 01-01-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
Azafaros BV
Azafaros BV Pharmaceuticals: MajorHealth Technology Develops therapeutic agents for the treatment of rare metabolic disorders | Financieel Directeur/CFO | 21-03-2023 |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Corporate Officer/Principal | 01-01-2020 |
Hagemeyer NV
Hagemeyer NV Wholesale DistributorsDistribution Services Distributes electrical parts and supplies | Corporate Officer/Principal | - |
PricewaterhouseCoopers BV
PricewaterhouseCoopers BV Miscellaneous Commercial ServicesCommercial Services Provides audit, assurance, tax and consulting services | Comptroller/Controller/Auditor | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
Hagemeyer NV
Hagemeyer NV Wholesale DistributorsDistribution Services Distributes electrical parts and supplies | Distribution Services |
Nyenrode Business Universiteit
Nyenrode Business Universiteit Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Health Technology |
PricewaterhouseCoopers BV
PricewaterhouseCoopers BV Miscellaneous Commercial ServicesCommercial Services Provides audit, assurance, tax and consulting services | Commercial Services |
Azafaros BV
Azafaros BV Pharmaceuticals: MajorHealth Technology Develops therapeutic agents for the treatment of rare metabolic disorders | Health Technology |
NewAmsterdam Pharma Co. NV
NewAmsterdam Pharma Co. NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches, develops, manufactures and commercializes transformative therapies for cardio-metabolic diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau